Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System

Clinical trial NCT01080209 · COMPLETED

Trial details

NCT number: NCT01080209
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Patients Who Participated in an Intravitreal Brimo PS DDS® Study

Start date: 2010-02-01
Primary completion: 2014-02-01
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.